Foresite Capital Fund IV, L.P. - Jan 31, 2025 SCHEDULE 13G Report for Maze Therapeutics, Inc. Common Stock, par value $0.001 (MAZE)

Filing Manager
Foresite Capital Fund IV, L.P.
Reporting Manager
James Tananbaum
Security
Maze Therapeutics, Inc. Common Stock, par value $0.001
Symbol
MAZE
Shares outstanding
43.9M shares
Disclosed Ownership
2.46M shares
Ownership
5.6%
Form type
SCHEDULE 13G
Date filed
2/7/2025, 04:01 PM
Date of event
Jan 31, 2025
Next filing
Nov 14, 2025
SEC
View on sec.gov

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Foresite Capital Fund IV, L.P. 4.8% 2.11M 2.11M 0 /s/ James Tananbaum James Tananbaum, Managing Member of the General Partner
Foresite Capital Management IV, LLC 4.8% 2.11M 2.11M 0 /s/ James Tananbaum James Tananbaum, Managing Member
Foresite Capital Fund V, L.P. 0.8% 345K 345K 0 /s/ James Tananbaum James Tananbaum, Managing Member of the General Partner
Foresite Capital Management V, LLC 0.8% 345K 345K 0 /s/ James Tananbaum James Tananbaum, Managing Member
James Tananbaum 5.6% 2.46M 2.46M 0 /s/ James Tananbaum James Tananbaum